Jeffery F. Miller
Fondateur chez Pylum Biosciences, Inc.
Postes actifs de Jeffery F. Miller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| David Geffen School of Medicine | Corporate Officer/Principal | - | - |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - | - |
| Fondateur | - | - |
Historique de carrière de Jeffery F. Miller
Anciens postes connus de Jeffery F. Miller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2005 | - |
| Fondateur | 01/01/2005 | - |
Formation de Jeffery F. Miller
| Tufts University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Health Technology |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Jeffery F. Miller
- Expérience
